Information date: 4 November 2026 — A counterparty screening requires four distinct checks, not one. MOFCOM publishes the Unreliable Entity List and the export-control dual-use item list; GACC publishes the register of customs credit status (AEO, general, dishonest) and import/export enterprise filings; BIS maintains the Entity List, the Denied Persons List and the Unverified List in the United States; and the Ministry of Public Security sanctions lists sit separately. Each list blocks something different: an Unreliable Entity listing restricts China-related trade and investment dealings, a BIS Entity List entry imposes a licence requirement on US-origin items, and a GACC dishonest-enterprise designation affects clearance speed and credit facilitation. If the counterparty appears on any list, stop and obtain legal analysis before signing — never rely on a verbal assurance. If it is clean, re-screen quarterly and on any change of control or ownership. If the transaction involves dual-use items, add a contractual clause requiring the counterparty to notify you of any listing within five business days and granting a suspension right, regardless of which jurisdiction’s list is involved.
Verified facts and scope
A counterparty screening requires four distinct checks, not one. MOFCOM publishes the Unreliable Entity List and the export-control dual-use item list; GACC publishes the register of customs credit status (AEO, general, dishonest) and import/export enterprise filings; BIS maintains the Entity List, the Denied Persons List and the Unverified List in the United States; and the Ministry of Public Security sanctions lists sit separately. Each list blocks something different: an Unreliable Entity listing restricts China-related trade and investment dealings, a BIS Entity List entry imposes a licence requirement on US-origin items, and a GACC dishonest-enterprise designation affects clearance speed and credit facilitation.
Scope has to be fixed before the numbers mean anything: Use for supplier onboarding, distributor appointment, M&A diligence and any transaction involving dual-use goods, semiconductors, drones, or items with US-origin technology content. Confirm before screening: the exact legal name in Chinese and English, the unified social credit code, the registered address and any former names. Screening a trade name alone produces both false positives and false negatives, because group subsidiaries are listed individually. Anything outside that set is a separate question with its own evidence requirement, and mixing the two is the most common way a workable plan turns into an unusable one.
For a decision on “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks”, keep three layers apart: the published rule or statistic, the company’s own orders and process records, and the assumptions nobody has tested yet. The first layer defines the external conditions, the second proves what is true for this business, and the third is where the risk actually sits. Public material cannot substitute for a contract, a system log, a sample or a live test.
A practical way to test the scope is to ask which parts of “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks” would still be true if the company changed supplier, entity or product line tomorrow. Items that survive that change belong to the rule layer and can be taken from official publications; items that do not survive belong to the operating layer and have to be rebuilt from invoices, warehouse records, customs entries or platform statements. Where Use for supplier onboarding, distributor appointment, M&A diligence and any transaction involving dual-use goods, semiconductors, drones, or items with US-origin technology content. Confirm before screening: the exact legal name in Chinese and English, the unified social credit code, the registered address and any former names. Screening a trade name alone produces both false positives and false negatives, because group subsidiaries are listed individually, the two layers are frequently mistaken for each other, and an action plan built on the wrong one either over-complies or misses a deadline it never saw coming.
How the effect reaches operations
Lists are entity-specific and jurisdiction-specific, so a company can be clean in China and restricted in the United States simultaneously, and a subsidiary can be listed while the parent is not. Export-control exposure follows the item, not the buyer: a Chinese counterparty that is unlisted can still trigger a licence if the goods contain controlled US technology. Unreliable Entity designation works differently — it targets the counterparty’s China-facing activities and can suspend its ability to import from or export to China, which is why it belongs in contract representations and termination triggers.
The standard failure is single-list screening performed once at onboarding and never refreshed. A second is assuming a listed entity’s Chinese subsidiary inherits the restriction, or conversely assuming it does not. A third is ignoring the 50 percent ownership rule in US controls, under which an entity owned half or more by a listed party is itself treated as listed. Signing a contract with no export-control representation, no suspension right and no audit access leaves you with no exit when a listing appears mid-term.
Translated into an operating sequence, Lists are entity-specific and jurisdiction-specific, so a company can be clean in China and restricted in the United States simultaneously, and a subsidiary can be listed while the parent is not. Export-control exposure follows the item, not the buyer: a Chinese counterparty that is unlisted can still trigger a licence if the goods contain controlled US technology. Unreliable Entity designation works differently — it targets the counterparty’s China-facing activities and can suspend its ability to import from or export to China, which is why it belongs in contract representations and termination triggers. That ordering matters: check applicability first, then the transmission step, and only then the size of the gap in cost or timing. When an intermediate step cannot be confirmed, the honest response is to narrow the scope of the conclusion rather than to substitute an industry average for the company’s own figures.
The cost of getting the order wrong is asymmetric. A team that checks applicability too late usually discovers it at the point where the shipment, the filing or the invoice can no longer be changed without penalty, and by then the only remaining lever is price. A team that checks early spends a few hours on questions that turn out to be irrelevant, which is cheap by comparison. On “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks” the practical rule is therefore to spend the first hour on scope and the second on the numbers, never the other way round.
Decision
If the counterparty appears on any list, stop and obtain legal analysis before signing — never rely on a verbal assurance. If it is clean, re-screen quarterly and on any change of control or ownership. If the transaction involves dual-use items, add a contractual clause requiring the counterparty to notify you of any listing within five business days and granting a suspension right, regardless of which jurisdiction’s list is involved.
The conditions should be written down so the decision can be re-run by someone else: Use for supplier onboarding, distributor appointment, M&A diligence and any transaction involving dual-use goods, semiconductors, drones, or items with US-origin technology content. Confirm before screening: the exact legal name in Chinese and English, the unified social credit code, the registered address and any former names. Screening a trade name alone produces both false positives and false negatives, because group subsidiaries are listed individually. When those hold, proceed as described; when one is missing, close the gap first and decide afterwards. A screening methodology note, not a legal opinion on export-control classification or licensing; the applicability of any list to a specific transaction requires counsel in the relevant jurisdiction.
Two workstreams usually have to move in parallel. The compliance workstream closes the document side of “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks” — registrations, confirmations, filings — while the commercial workstream protects the delivery date, the pricing already quoted and the customer commitments that were made on the earlier reading of the rules. Running them as one queue is how small documentation gaps become missed shipment dates: the commercial side waits for a certificate that could have been requested a week earlier. If the counterparty appears on any list, stop and obtain legal analysis before signing — never rely on a verbal assurance. If it is clean, re-screen quarterly and on any change of control or ownership. If the transaction involves dual-use items, add a contractual clause requiring the counterparty to notify you of any listing within five business days and granting a suspension right, regardless of which jurisdiction’s list is involved. Set one owner per workstream and one shared status sheet, and treat a red item on either side as a reason to freeze only the affected order.
Implementation checklist
- Screen the full legal name and credit code against MOFCOM, GACC and BIS lists and save the dated results.
- Insert export-control representations, notification duties and suspension rights into the supply contract.
- Set a quarterly re-screening calendar with ownership-change triggers.
- Name one decision owner, one execution owner and one review date.
- Keep the source page, access date, entity and internal evidence.
- On any change, reopen only the affected judgement.
Evidence and review
Start with the smallest test that can change the answer: Screen the full legal name and credit code against MOFCOM, GACC and BIS lists and save the dated results. Pick one real entity or one representative case, write down the continue, watch and stop conditions in advance, and record the input version, the owner, the start time and the actual result. The first pass should only look at facts that move the decision; formatting preferences are not risk.
The second pass is completed by “Insert export-control representations, notification duties and suspension rights into the supply contract”, and someone who did not prepare the file should spot-check one piece of critical evidence. The standard failure is single-list screening performed once at onboarding and never refreshed. A second is assuming a listed entity’s Chinese subsidiary inherits the restriction, or conversely assuming it does not. A third is ignoring the 50 percent ownership rule in US controls, under which an entity owned half or more by a listed party is itself treated as listed. Signing a contract with no export-control representation, no suspension right and no audit access leaves you with no exit when a listing appears mid-term. A single small deviation can be corrected in place; a repeated deviation, or one that touches a statutory duty or changes the economics, is what justifies pausing the affected part.
After “Set a quarterly re-screening calendar with ownership-change triggers”, compare the actual result with the baseline rather than with the impression of the team. If the counterparty appears on any list, stop and obtain legal analysis before signing — never rely on a verbal assurance. If it is clean, re-screen quarterly and on any change of control or ownership. If the transaction involves dual-use items, add a contractual clause requiring the counterparty to notify you of any listing within five business days and granting a suspension right, regardless of which jurisdiction’s list is involved. When the arrangement is extended to more products, customers or processes, keep the same success test and one complete record per batch. If later information changes, update only the affected fields.
One last discipline keeps the file usable next quarter: write the closing note as if a colleague who has never spoken to the supplier has to act on it. That note states what was verified, on which date, against which source, and what remains open — on “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks” it also states which of the three actions was actually finished and which was only scheduled. Teams that skip the closing note re-litigate the same question every month, and each round costs more than the documentation would have. A screening methodology note, not a legal opinion on export-control classification or licensing; the applicability of any list to a specific transaction requires counsel in the relevant jurisdiction.
Limits of the conclusion
A screening methodology note, not a legal opinion on export-control classification or licensing; the applicability of any list to a specific transaction requires counsel in the relevant jurisdiction.
The limits are structural rather than cautious wording. Public sources describe rules and market conditions; they do not observe “Resources: Where to Check a Chinese Counterparty Against Export-Control and Unreliable-Entity Lists — MOFCOM, GACC and BIS Look-Up Points and What Each Listing Actually Blocks” inside a specific company. Where the analysis quotes a second-hand interpretation, the original release has to remain reachable, and a figure that cannot be traced back does not enter the decision table. Where the point depends on Use for supplier onboarding, distributor appointment, M&A diligence and any transaction involving dual-use goods, semiconductors, drones, or items with US-origin technology content. Confirm before screening: the exact legal name in Chinese and English, the unified social credit code, the registered address and any former names. Screening a trade name alone produces both false positives and false negatives, because group subsidiaries are listed individually, the conclusion is only as current as the last check of those conditions.
